Name: Balancing Blood Pressure in Subarachnoid Hemorrhage: The Role of Vasopressors During Nimodipine Administration
Start: 2026-05-18T11:00:00-0400
End: 2026-05-18T11:20:00-0400

Balancing Blood Pressure in Subarachnoid Hemorrhage: The Role of Vasopressors During Nimodipine Administration

Monday May 18, 2026 11:00am - 11:20am EDT

Broad Hub EAST

Purpose: The purpose of this study was to determine the differences in outcomes between patients who received nimodipine with and without vasopressors initially presenting with subarachnoid hemorrhage.
Methods: This was a retrospective single center study which included patients between ages 18 and 65 years of age who experienced subarachnoid hemorrhage and received nimodipine for the prevention of vasospasm and delayed cerebral ischemia. Patients who received at least one vasopressor were assigned to the vasopressor group and compared to patients who received nimodipine alone. Patients were excluded from the study if they were transferred from a hospital not within the Penn State Health network within 48 hours of hemorrhage, left against medical advice within 7 days of admission or died during admission. The primary outcome was length of intensive care unit stay. Secondary outcomes included the duration of nimodipine therapy, duration of vasopressor therapy, and discharge disposition.
Results/Conclusions: Between 2018 and 2025, a total of 153 patients were included in the study. A total of 34 patients were included in the group who received nimodipine and at least one vasopressor, and 119 patients were included in the nimodipine alone group. The average duration of ICU length of stay was 16.1 days in the vasopressor group versus 9.9 days in the group who received nimodipine alone. At the time of submission of this abstract, secondary outcomes and data analysis of all endpoints are in progress.

Moderators

Kayla Bardzel

Neurocritical Care Clinical Specialist, Penn State Health Milton S. Hershey Medical Center

Michael Hasbrouck

Natalie Kong, PharmD, BCPS

PGY1 RPD, Lankenau Medical Center

Speakers

Morgan Gerber

PGY2 Critical Care, Milton S. Hershey Medical Center

Completed PGY1 at Milton S. Hershey Medical Center and am a current PGY-2 Critical Care Resident at Milton S. Hershey Medical Center. Have accepted a position as an Emergency Medicine/Critical Care pharmacy specialist at Milton S. Hershey Medical Center.

Monday May 18, 2026 11:00am - 11:20am EDT
Broad Hub EAST

Critical Care

PSHP 2026 Residency Conference

Kayla Bardzel

Michael Hasbrouck

Natalie Kong, PharmD, BCPS

Morgan Gerber

Attendees (16)

Get help with the event

PSHP 2026 Residency Conference

Kayla Bardzel

Michael Hasbrouck

Natalie Kong, PharmD, BCPS

Morgan Gerber

Attendees (16)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event